<table class="naaccr-summary-table naaccr-borders">
    <tr>
        <th class="naaccr-summary-header naaccr-borders">Alternate Name</th>
        <th class="naaccr-summary-header naaccr-borders">Item #</th>
        <th class="naaccr-summary-header naaccr-borders">Length</th>
        <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
        <th class="naaccr-summary-header naaccr-borders">Implemented Year</th>
        <th class="naaccr-summary-header naaccr-borders">Implemented Version</th>
        <th class="naaccr-summary-header naaccr-borders">Retired Year</th>
        <th class="naaccr-summary-header naaccr-borders">Retired Version</th>
        <th class="naaccr-summary-header naaccr-borders">Column #</th>
    </tr>
    <tr>
        <td class="naaccr-summary-cell naaccr-borders">Type of First Recurrence (CoC)<br/></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1880</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">CoC</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2206 - 2207</td>
    </tr>
</table>

<div class='content chap10-para-head'><strong><strong>Description</strong></strong></div>
<div class='content chap10-para'>Code for the type of first recurrence after a period of documented disease free intermission or remission.</div>
<div class='content chap10-para'><strong>Codes</strong></div>
<div class='content chap10-para'>
    <table>
        <tr class='code-row'>
            <td class='code-nbr'>00</td>
            <td class='code-desc'>Patient became disease-free after treatment and has not had a recurrence; leukemia in remission.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>04</td>
            <td class='code-desc'><i>In situ</i> recurrence of an invasive tumor.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>06</td>
            <td class='code-desc'><i>In situ</i> recurrence of an <i>in situ</i> tumor.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>10</td>
            <td class='code-desc'>Local recurrence and there is insufficient information available to code to 13-17. Recurrence is confined to the remnant of the organ of origin; to the organ of origin; to the anastomosis; or to scar tissue where the organ previously existed.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>13</td>
            <td class='code-desc'>Local recurrence of an invasive tumor.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>14</td>
            <td class='code-desc'>Trocar recurrence of an invasive tumor. Includes recurrence in the trocar path or entrance site following prior surgery.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>15</td>
            <td class='code-desc'>Both local and trocar recurrence of an invasive tumor (both 13 and 14)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>16</td>
            <td class='code-desc'>Local recurrence of an <i>in situ</i> tumor.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>17</td>
            <td class='code-desc'>Both local and trocar recurrence of an <i>in situ</i> tumor.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>20</td>
            <td class='code-desc'>Regional recurrence, and there is insufficient information available to code to 21-27.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>21</td>
            <td class='code-desc'>Recurrence of an invasive tumor in adjacent tissue or organ(s) only.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>22</td>
            <td class='code-desc'>Recurrence of an invasive tumor in regional lymph nodes only.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>25</td>
            <td class='code-desc'>Recurrence of an invasive tumor in adjacent tissue or organ(s) and in regional lymph nodes (both 21 and 22) at the same time.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>26</td>
            <td class='code-desc'>Regional recurrence of an <i>in situ</i> tumor, NOS.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>27</td>
            <td class='code-desc'>Recurrence of an <i>in situ</i> tumor in adjacent tissue or organ(s) and in regional lymph nodes at the same time.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>30</td>
            <td class='code-desc'>Both regional recurrence of an invasive tumor in adjacent tissue or organ(s) and/or regional lymph nodes (20-25) and local and/or trocar recurrence (10, 13, 14, or 15).</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>36</td>
            <td class='code-desc'>Both regional recurrence of an
                <i>in situ</i> tumor in adjacent tissue or organ(s) and/or regional lymph nodes (26 or 27) and local and/or trocar recurrence (16 or 17).
            </td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>40</td>
            <td class='code-desc'>Distant recurrence and there is insufficient information available to code to 46-62.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>46</td>
            <td class='code-desc'>Distant recurrence of an <i>in situ</i> tumor.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>51</td>
            <td class='code-desc'>Distant recurrence of an invasive tumor in the peritoneum only. Peritoneum includes peritoneal surfaces of all structures within the abdominal cavity and/or positive ascitic fluid.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>52</td>
            <td class='code-desc'>Distant recurrence of an invasive tumor in the lung only. Lung includes the visceral pleura.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>53</td>
            <td class='code-desc'>Distant recurrence of an invasive tumor in the pleura only. Pleura includes the pleural surface of all structures within the thoracic cavity and/or positive pleural fluid.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>54</td>
            <td class='code-desc'>Distant recurrence of an invasive tumor in the liver only.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>55</td>
            <td class='code-desc'>Distant recurrence of an invasive tumor in bone only. This includes bones other than the primary site.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>56</td>
            <td class='code-desc'>Distant recurrence of an invasive tumor in the CNS only. This includes the brain and spinal cord, but not the external eye.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>57</td>
            <td class='code-desc'>Distant recurrence of an invasive tumor in the skin only. This includes skin other than the primary site.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>58</td>
            <td class='code-desc'>Distant recurrence of an invasive tumor in lymph node only. Refer to the staging scheme for a description of lymph nodes that are distant for a particular site.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>59</td>
            <td class='code-desc'>Distant systemic recurrence of an invasive tumor only. This includes leukemia, bone marrow metastasis, carcinomatosis, and generalized disease.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>60</td>
            <td class='code-desc'>Distant recurrence of an invasive tumor in a single distant site (51-58) and local, trocar, and/or regional recurrence (10-15, 20-25, or 30).</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>62</td>
            <td class='code-desc'>Distant recurrence of an invasive tumor in multiple sites (recurrences that can be coded to more than one category 51-59).</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>70</td>
            <td class='code-desc'>Since diagnosis, patient has never been disease-free. This includes cases with distant metastasis at diagnosis, systemic disease, unknown primary, or minimal disease that is not treated.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>88</td>
            <td class='code-desc'>Disease has recurred, but the type of recurrence is unknown.</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>99</td>
            <td class='code-desc'>It is unknown whether the disease has recurred or if the patient was ever disease-free.</td>
        </tr>
    </table>
</div>